News
Epilepsy is one of the most common neurological diseases in the world, ... Algorithm better identifies the origin of a seizure to guide more precise surgical interventions.
A seizure-predicting algorithm like Empatica’s work-in-progress is “among the most-requested features for people with epilepsy,” Rosalind Picard, Ph.D., a co-founder of the company and its ...
DENVER – A machine-learning seizure burden monitoring algorithm was able to predict the level of poor functional outcomes in those with neurological conditions, according to new research.
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year ...
For this article, EMJ conducted an interview with Ahmed Abdelmoity, Professor and Director, Division of Neurology, Children’s ...
CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, with upcoming earnings on 02/25 a catalyst. Read more here.
A new tool could potentially reduce epilepsy misdiagnoses by up to 70%, new research suggests. Known as EpiScalp, the tool uses algorithms trained on dynamic network models to map brainwave ...
Ceribell has received 510(k) clearance for an algorithm that detects seizures in patients ages one year and older. The company, which announced the news Tuesday, ...
EpiMonitor is a medical-grade wearable solution for people living with epilepsy. Designed for daily life, it combines night & day, high-accuracy seizure monitoring with comprehensive health tracking.
FDA clearance of Ceribell’s Clarity™ algorithm will enable rapid, bedside detection, diagnosis, and treatment of non-convulsive seizures in children experiencing neurological emergencies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results